Overland Park, KS (March 21, 2025) - The American Association of Veterinary State Boards, in conjunction with volunteer working groups comprised of subject matter experts, regulatory board members and staff, private practitioners, and industry leaders has produced this white paper: "Regulatory Considerations of the Use of Artificial Intelligence in Veterinary Medicine."
This paper examines the regulatory considerations of AI use in veterinary medicine. As AI and other emerging technologies become more widely adopted, the need arises for clear guidance from regulatory bodies on its responsible use to protect Patients and the public.
After thorough analysis and discussion on this expansive and still evolving topic, AAVSB provides a position statement as follows:
“The American Association of Veterinary State Boards (AAVSB) supports innovation. We recognize the potential benefits that Artificial Intelligence (AI) and other emerging technologies may offer the veterinary profession. However, Licensees must understand the risks and limitations of AI to protect the standard of Patient care and prevent unlicensed practices. They must also maintain full transparency regarding AI use, safeguard Client data privacy, and, when appropriate, obtain Informed Consent for the use of AI.”
With any questions or comments, please contact Dr. Beth Venit, AAVSB Chief Veterinary Officer at [email protected].
For more information about the AAVSB, please visit our 'about us' page.
About the AAVSB: The AAVSB is a 501(c)(3) non-profit organization whose mission is to strengthen the veterinary regulatory community. The membership of the AAVSB consists of 63 jurisdictions representing all of the United States and the District of Columbia, Puerto Rico, the U.S. Virgin Islands, the ten Canadian provinces.